参考文献

［1］ DOVEY DE LA COUR C, GULERIA S, NYGARD M, ET AL. Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention. Cancer Med. 2019 Feb; 8 (2): 839-849.

［2］ RITU W, ENQI W, ZHENG S, et al. Evaluation of the associations between cervical microbiota and HPV infection, clearance, and persistence in cytologically normal women. Cancer prevention research, Cancer Prev Res (Phila), 2019, 12 (1): 43-56.

［3］ MITRA A, MACINTYRE D A, MARCHESI J R, et al. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next？Microbiome, 2016, 4 (1): 58.

［4］ MITRA A, MACINTYRE DA, Lee YS, et al. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci Rep, 2015, 5: 16865.

［5］ XU X, WANG H, MA D, et al. Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat Genet, 2015,2: 47 (2): 158-163.

［6］ CHRISTIANSEN IK, SANDVE GK, SCHMITZ M, et al. Transcriptionally active regions are the preferred targets for chromosomal HPV integration in cervical carcinogenesis. PLoS ONE, 2015, 10 (3): e0119566.

［7］ HOCHMANN J, PARITTI F, Martine Z, et al. Human papillomavirus type 18 E5 oncoprotein cooperates with E6 and E7 in promoting cell viability and invasion and in modulating the cellular redox state. Mem. Inst. Oswaldo Cruz, 2020, 115: e190405.

［8］ FIANO V, TREVISAN M, FASANELLI F, et al. Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women, Gynecol Oncol, 2018, 151 (2): 319-326.

［9］ HU Y, HONG Z, GU L, et al. Evaluation of p16/Ki-67 Dual-stained Cytology in Triaging HPV-Positive Women During Cervical Cancer Screening. Cancer Epidemiol Biomarkers Prev. 2020, 29 (3): 1246-1252.

［10］ STRUYF F, COLAU B, WHEELER C M, et al. Efficacy of human papilloma virus (HPV)-16/18 AS04-adjuvanted vaccine against incident and persistent infection with non-vaccine oncogenic HPV types using an alternativemultiplex type-specific PCR assay for HPV DNA: post hoc analysis from the PATRICIA rand. Clinical & Vaccine Immunology, 2015, 22 (2): 235-244.

［11］ FITZGERALD G, SORO-ARNAIZ I, DE BOCK K, et al. The Warburg Effect in Endothelial Cells and its Potential as an Anti-angiogenic Target in Cancer.Front Cell Dev Biol 2018，6 ：100.